Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. - Wikidata - awgldk - TriplyDB

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q54739404

about

Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings Satellite cells in human skeletal muscle plasticity Myostatin: expanding horizons Pharmacology of manipulating lean body mass The mechanisms of cachexia underlying muscle dysfunction in COPD Muscle function in COPD: a complex interplay Role of autophagy in COPD skeletal muscle dysfunction Inflammation induced loss of skeletal muscle Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.Alterations in skeletal muscle cell homeostasis in a mouse model of cigarette smoke exposure.Reduced HDAC2 in skeletal muscle of COPD patients.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients Molecular adaptations to aerobic exercise training in skeletal muscle of older women.Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1 The order of exercise during concurrent training for rehabilitation does not alter acute genetic expression, mitochondrial enzyme activity or improvements in muscle function CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro.The ubiquitin ligase Nedd4-1 participates in denervation-induced skeletal muscle atrophy in mice.Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle.Quadriceps myostatin expression in COPD Reduced myotube diameter, atrophic signalling and elevated oxidative stress in cultured satellite cells from COPD patients.Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients.Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls.Nutrition and respiratory health--feature review.Effect of pulmonary TNF-α overexpression on mouse isolated skeletal muscle function The role of Interleukin 15 in protein degradation in skeletal muscles in rats of chronic obstructive pulmonary disease.High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation.FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy.Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.Association of plasma adiponectin levels with cellular hydration state measured using bioelectrical impedance analysis in patients with COPD Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.Vitamin D deficiency impairs skeletal muscle function in a smoking mouse model Fifteen days of 3,200 m simulated hypoxia marginally regulates markers for protein synthesis and degradation in human skeletal muscle.Role of microRNAs in skeletal muscle hypertrophy.The posterior cricoarytenoid muscle is spared from MuRF1-mediated muscle atrophy in mice with acute lung injury.Superoxide release from contracting skeletal muscle in pulmonary TNF-α overexpression mice.

P2860

Q24609841-F1B4A046-91CA-450E-A6E2-B822A5DC9D12 Q26749418-027ABA91-C328-407F-96D0-CA2E1D0CD3C1 Q26775701-E84058BE-6DCF-42D9-B8B7-12FECF2AF960 Q26777962-6FD6F657-DDE7-4313-A6E3-268815F5DAE7 Q26797484-938F9304-C52D-466D-9FA9-C9A92EAEBFB0 Q26824503-AB3368FB-43B3-4A0D-9F8A-D9F024EE8F90 Q26828616-68BEB1E2-9635-4A32-B072-E2DC3AF46773 Q26865732-6BE8B937-1B0D-4C3D-AC57-9E27F5EF587A Q27015002-CE987063-2D4E-4B77-B6A3-9A62901435AE Q28083759-EAE452FA-C3D7-46F3-A40D-CE3943316C24 Q30251635-6B8B9F8C-4990-4B49-968E-D008BFC92912 Q31120982-993681E1-A47E-4D57-847C-5ACA5EA570FB Q33708989-601F179D-A9D2-403A-A0C9-AFEAC9790C4B Q33901722-B8198E60-6D95-47A1-8D7E-0E493D24DDC5 Q34061404-37270FA4-CCF3-4706-B3C7-881DAB50C42E Q34195213-CC56AA0B-90EB-4B04-885B-A02DAB5B7DD3 Q34200869-59BB76CF-C072-4329-944A-DEB8D1400BD0 Q34301737-D9971313-AD6A-40E0-B634-ECED9FE37B22 Q34429152-46B7B6E0-FDCD-4FD1-BCB2-C8C31FD04B3C Q34460314-C3E58E81-D695-457D-ABFC-868F66895654 Q34501675-846C2C0F-F968-4BB4-ABDB-FC8B5461EC24 Q34575091-36D7E011-EFAE-49EC-BF47-BCD90211A3B1 Q34885462-1AED5353-AFB1-4FA4-BCD7-DF1BC21C2502 Q35049028-A2A17977-FD17-4A21-B331-DA9868ED73B1 Q35097330-D7459DE1-2FCD-454E-980A-7C0858F8DFC6 Q35227855-8F860093-AEBF-4206-B4F4-6C76DBB63B82 Q35396763-E4C156E0-8064-4BE9-8DAB-13C19CC12254 Q35479689-3EE31B43-4CB2-4523-94B1-F9E614706C9F Q35580888-0E581BB1-F019-486C-9739-A7B9E7EF71CB Q36028202-124ABB1E-2BE6-4C65-B129-F6F40509B3B4 Q36055551-E5274A4A-2CB4-44A0-B3E6-AC05CF19FC24 Q36076177-5FD6F9D6-B163-471F-AF3F-63C7AB1FDE57 Q36104189-67510DCB-CCE2-4A94-B6C1-1BA8BCD4CB42 Q36173154-9652381A-21BF-49FA-A2B6-3A3470A4EBB0 Q37140393-EC8EC6A0-4364-4742-9009-25BAD8DE7660 Q37340545-0A722EA2-48FF-4001-BF0A-812B01AFEE8D Q37376694-4342A22E-6F0E-4B15-BAC5-355E175BD055 Q37485727-DE38922A-9221-4FF1-A925-D5AE899D931C Q37539031-CCE69C10-0528-46E3-9A78-9D66B1BC605C Q37578142-F19624B2-0738-431A-B497-867D9A302DD8

P2860

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q54739404

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

@en

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

@nl

type

label

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

@en

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

@nl

prefLabel

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

@en

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

@nl

P1433

Q54739404-7AD3EA21-3B35-4066-BF29-7511420DA6F7

P1476

Q54739404-60B797ED-C95E-45EA-8FD1-849FD7ADB4A8

P2093

Q54739404-1AAE0CE5-5097-41B1-AC64-89D3399F065E

Q54739404-258F3CF8-ED21-435E-B915-0266E1EA6182

Q54739404-434BD667-B624-4504-B25E-1B8AA01A3C40

Q54739404-500ABF3A-7D34-4FBE-B353-F236192FE8CE

Q54739404-573A3D02-11EF-4A22-B25F-EB0A31A435A9

Q54739404-6D0A7123-E099-4DE7-BBA1-B27F04381837

Q54739404-6DF9FA37-5C28-488B-9AE0-04DCC86EBEF0

Q54739404-877371B1-3C01-42FA-8051-F68521EF3516

Q54739404-9E14CCA1-317D-4544-9DCF-6AD59A37BC76

P2860

Q54739404-01E05E15-DC8A-4779-806A-DF849F460ADB

Q54739404-061DE536-0F31-4C0F-8954-4AF5AC4C3622

Q54739404-091F82C4-C93F-4188-8C7A-013EB16830B7

Q54739404-0AA954CD-4C30-48FB-979D-B5E8017C1887

Q54739404-0AFB727D-556B-4C3E-819A-4FF4DF28480E

Q54739404-0BDA577C-E19D-4629-BAF6-B735248AD5F3

Q54739404-128DC5CE-13A3-4E5F-BF26-B24D5478C011

Q54739404-142021D8-0FAF-4F8C-87E7-EB5B1CF092F4

Q54739404-18D8E79D-D2DD-440B-A558-BFAC7C07402D

Q54739404-25FD7C58-9644-41F8-91B6-CC3AF57705F0

P304

Q54739404-0DAAE682-014E-49B4-AFAF-B8C8DF552A1A

P31

Q54739404-A56674FB-7414-40AA-BB94-D710F6ABB6EB

P356

Q54739404-E937E823-E9D7-4CAA-9429-D950E74AD02A

P433

Q54739404-3F3EF22B-D747-464D-82FC-1669F20B6A7D

P478

Q54739404-245AE4AE-2A14-4DED-93B8-DE363D1ACEE2

P50

Q54739404-EFB4E2D8-0429-41BB-B2BE-FF6E5C30399C

P577

Q54739404-0784AE37-D30A-4F7C-9323-76521F7ECBCE

P698

Q54739404-233F7ED1-FDA5-4991-9317-53CCA4B2DC30

P921

Q54739404-86761267-5B97-46FC-B0B0-2E21233BE9D4

P356

RCMB.2008-0382OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Cellular markers of muscle atrophy in chronic obstructive pulmonary disease

@en

P2093

Dawn Pearce

http://www.w3.org/2001/XMLSchema#string

Dina Brooks

http://www.w3.org/2001/XMLSchema#string

James Bain

http://www.w3.org/2001/XMLSchema#string

Jane Batt

http://www.w3.org/2001/XMLSchema#string

Judy Correa

http://www.w3.org/2001/XMLSchema#string

Marie Faughnan

http://www.w3.org/2001/XMLSchema#string

Matthew Binnie

http://www.w3.org/2001/XMLSchema#string

Pamela J Plant

http://www.w3.org/2001/XMLSchema#string

Tanya Bayley

http://www.w3.org/2001/XMLSchema#string

P2860

Human ubiquitin-protein ligase Nedd4: expression, subcellular localization and selective interaction with ubiquitin-conjugating enzymes

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I

Apical membrane targeting of Nedd4 is mediated by an association of its C2 domain with annexin XIIIb

Mechanisms underlying ubiquitination

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

Cellular and molecular regulation of muscle regeneration

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states

MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination

P304

461-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2008-0382OC

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Lianne G Singer

P577

2009-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19520920

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease